Agios Pharmaceuticals: 2Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $68.7 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of $1.19 per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.62 per share.
The biopharmaceutical company posted revenue of $40.4 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $12.1 million.
Agios Pharmaceuticals shares have increased 52 percent since the beginning of the year. The stock has risen 48 percent in the last 12 months.